Development of host resistance to Ancylostoma ceylanicum after the elimination of primary infection with oxfendazole.
D000724:Ancylostomiasis / Q000188:drug therapy / Q000276:immunology*; D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D006224:Cricetinae; D005260:Female; D006790:Host-Parasite Interactions; D008297:Male
D000871:Anthelmintics; D001562:Benzimidazoles; C011030:oxfendazole